SmartAlpha

SmartAlpha

Artificial intelligence solutions for healthcare professionals.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
N/A

€0.0

Valuation: €0.0

round
investor

€0.0

Valuation: €0.0

round
investor

€0.0

Valuation: €0.0

round
investor investor

€0.0

round

$1.2m

Valuation: $12.4m

Seed
Total Funding000k

Financials

Estimates*

Get premium to view all results
Edit
Revenues, earnings & profits over time
USD20212023
Revenues00000000
EBITDA00000000
Profit00000000
EV00000000
EV / revenue00.0x00.0x
EV / EBITDA00.0x00.0x
R&D budget00000000

Source: Dealroom estimates

More about SmartAlpha
Made with AI
Edit

SmartAlpha.ai is a cutting-edge startup focused on revolutionizing the field of ultrasound imaging through advanced artificial intelligence (AI). The company aims to make ultrasound imaging accessible anywhere, anytime, and by any healthcare worker, addressing the growing demand on physicians to extend their reach to more patients. SmartAlpha.ai operates in the healthcare technology market, specifically targeting medical professionals such as anesthesiologists who use ultrasound for administering regional anesthesia, known as Peripheral Nerve Blocks.

The core of SmartAlpha.ai's innovation lies in its AI-guided assistance technology. This technology enhances the capabilities of ultrasound devices, making them more user-friendly and effective. By leveraging AI, the company ensures that even healthcare workers with minimal training can perform ultrasound imaging accurately and efficiently. This is particularly beneficial in settings where access to highly trained specialists is limited.

SmartAlpha.ai's business model revolves around the development and sale of AI-enhanced ultrasound solutions. The company generates revenue through the sale of its proprietary software and devices, as well as through partnerships with third-party service providers such as advertisers, contest sponsors, and promotional partners. One of its flagship products, Nerveblox, is a CE-marked medical device, indicating compliance with EU safety, health, and environmental protection standards. This product is specifically designed to assist anesthesiologists in performing Peripheral Nerve Blocks more effectively.

The company adheres to Good Clinical Practice (GCP) standards, which are international ethical and scientific quality standards for designing, conducting, recording, and reporting trials involving human subjects. This commitment ensures that SmartAlpha.ai's products are not only innovative but also ethically credible and safe for clinical use.

In summary, SmartAlpha.ai is at the forefront of making ultrasound imaging more accessible and efficient through AI technology, serving healthcare professionals in various settings, and ensuring high standards of safety and ethics.

Keywords: AI, ultrasound, healthcare, imaging, anesthesiology, Nerveblox, Peripheral Nerve Blocks, CE-marked, GCP standards, medical technology.

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads